| - GRCh38:
- Chr16:46385317-61223349
| NLRC5, NOD2, NUDT21, NUP93, POLR2C, PRSS54, PSME3IP1, NUP93-DT, ORC6, PHKB, RBL2, RPGRIP1L, RSPRY1, SALL1, OGFOD1, PLLP, MIR6771, MIR6772, MIR6863, MMP15, MMP2, MMP2-AS1, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, MT2A, MT3, MT4, MYLK3, N4BP1, NDRG4, NETO2, NKD1, SETD6, SHCBP1, SIAH1, SLC12A3, SLC38A7, SLC6A2, SNORA46, SNORA50A, SNORD148, SNX20, TENT4B, TEPP, TOX3, TRL-CAG2-1, TRL-CAG2-2, USB1, VPS35, ZNF319, ZNF423, ABCC11, ABCC12, ADCY7, ADGRG1, ADGRG3, ADGRG5, AKTIP, AMFR, ARL2BP, BBS2, BRD7, C16orf78, C16orf87, CAPNS2, CASC16, CASC22, CBLN1, CCDC102A, CCDC113, CCL17, CCL22, CES1, CES5A, CETP, CFAP20, CHD9, CHD9NB, CIAPIN1, CNEP1R1, CNGB1, CNOT1, COQ9, CPNE2, CRNDE, CSNK2A2, CX3CL1, CYLD, CYLD-AS1, DNAJA2, DOK4, DRC7, FTO, FTO-IT1, GINS3, GNAO1, GNAO1-AS1, GNAO1-DT, GOT2, GPT2, HEATR3, HERPUD1, HNRNPA1L3, IRX3, IRX5, IRX6, ITFG1, ITFG1-AS1, KATNB1, KIFC3, LINC00919, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02137, LINC02140, LINC02141, LINC02168, LINC02169, LINC02178, LINC02179, LINC02180, LINC02192, LINC02911, LINC03064, LOC100507577, LOC101927272, LOC101927480, LOC102723373, LOC110120574, LOC110120575, LOC110120576, LOC110120577, LOC110120578, LOC110120579, LOC110120580, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120835, LOC110120836, LOC110120837, LOC110120838, LOC110120839, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC110121356, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC112449716, LOC112449717, LOC112469003, LOC112469004, LOC112469005, LOC112469006, LOC112469007, LOC112469008, LOC112469009, LOC112469010, LOC112469011, LOC112469012, LOC112469013, LOC112469014, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121587546, LOC121587547, LOC121587548, LOC121847987, LOC121847988, LOC121847989, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC125177313, LOC125177314, LOC125177315, LOC125177316, LOC125177317, LOC125177318, LOC125177319, LOC125177320, LOC125177322, LOC125177323, LOC125177324, LOC125177325, LOC125177326, LOC125177327, LOC125177328, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, LOC126862355, LOC126862356, LOC126862357, LOC126862358, LOC126862359, LOC126862360, LOC126862361, LOC126862362, LOC126862363, LOC126862364, LOC388282, LONP2, LPCAT2, MIR138-2, MIR3181, MIR3935 | | not provided | Pathogenic (Jul 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:46500741-52456082
- GRCh38:
- Chr16:46466829-52422170
| ABCC11, ABCC12, ADCY7, BRD7, C16orf78, C16orf87, CASC22, CBLN1, CNEP1R1, CYLD, CYLD-AS1, DNAJA2, GPT2, HEATR3, HNRNPA1L3, ITFG1, ITFG1-AS1, LINC00919, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02168, LINC02178, LINC02179, LINC02180, LINC02192, LINC02911, LOC100507577, LOC101927272, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121847987, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LONP2, MIR3181, MIR6771, MYLK3, N4BP1, NETO2, NKD1, NOD2, ORC6, PHKB, SALL1, SHCBP1, SIAH1, SNORD148, SNX20, TENT4B, VPS35, ZNF423 | | See cases | Pathogenic (Apr 8, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr16:46500741-52389705
- GRCh38:
- Chr16:46466829-52355793
| ABCC11, ABCC12, ADCY7, BRD7, C16orf78, C16orf87, CASC22, CBLN1, CNEP1R1, CYLD, CYLD-AS1, DNAJA2, GPT2, HEATR3, HNRNPA1L3, ITFG1, ITFG1-AS1, LINC00919, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02168, LINC02178, LINC02179, LINC02180, LINC02192, LINC02911, LOC100507577, LOC101927272, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120841, LOC110120912, LOC110120939, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121847987, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LONP2, MIR3181, MIR6771, MYLK3, N4BP1, NETO2, NKD1, NOD2, ORC6, PHKB, SALL1, SHCBP1, SIAH1, SNORD148, SNX20, TENT4B, VPS35, ZNF423 | | See cases | Pathogenic (Dec 22, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr16:46500741-51707107
- GRCh38:
- Chr16:46466829-51673196
| ABCC11, ABCC12, ADCY7, BRD7, C16orf78, C16orf87, CBLN1, CNEP1R1, CYLD, CYLD-AS1, DNAJA2, GPT2, HEATR3, HNRNPA1L3, ITFG1, ITFG1-AS1, LINC02127, LINC02128, LINC02133, LINC02134, LINC02168, LINC02178, LINC02179, LINC02192, LOC100507577, LOC101927272, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120841, LOC110120912, LOC110120939, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121847987, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LONP2, MIR3181, MIR6771, MYLK3, N4BP1, NETO2, NKD1, NOD2, ORC6, PHKB, SALL1, SHCBP1, SIAH1, SNORD148, SNX20, TENT4B, VPS35, ZNF423 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr16:46500741-51973216
- GRCh38:
- Chr16:46466829-51939304
| ABCC11, ABCC12, ADCY7, BRD7, C16orf78, C16orf87, CBLN1, CNEP1R1, CYLD, CYLD-AS1, DNAJA2, GPT2, HEATR3, HNRNPA1L3, ITFG1, ITFG1-AS1, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02168, LINC02178, LINC02179, LINC02192, LOC100507577, LOC101927272, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120841, LOC110120912, LOC110120939, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121847987, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LONP2, MIR3181, MIR6771, MYLK3, N4BP1, NETO2, NKD1, NOD2, ORC6, PHKB, SALL1, SHCBP1, SIAH1, SNORD148, SNX20, TENT4B, VPS35, ZNF423 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr16:46505432-52439868
- GRCh38:
- Chr16:46471520-52405956
| ABCC11, ABCC12, ADCY7, BRD7, C16orf78, C16orf87, CASC22, CBLN1, CNEP1R1, CYLD, CYLD-AS1, DNAJA2, GPT2, HEATR3, HNRNPA1L3, ITFG1, ITFG1-AS1, LINC00919, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02168, LINC02178, LINC02179, LINC02180, LINC02192, LINC02911, LOC100507577, LOC101927272, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120841, LOC110120912, LOC110120939, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121847987, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LONP2, MIR3181, MIR6771, MYLK3, N4BP1, NETO2, NKD1, NOD2, ORC6, PHKB, SALL1, SHCBP1, SIAH1, SNORD148, SNX20, TENT4B, VPS35, ZNF423 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr16:47284555-54155388
- GRCh38:
- Chr16:47250644-54121476
| ABCC11, ABCC12, ADCY7, AKTIP, BRD7, C16orf78, CASC16, CASC22, CBLN1, CHD9, CHD9NB, CNEP1R1, CYLD, CYLD-AS1, FTO, FTO-IT1, HEATR3, HNRNPA1L3, ITFG1, LINC00919, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02168, LINC02178, LINC02179, LINC02180, LINC02192, LINC02911, LINC03064, LOC100507577, LOC101927272, LOC102723373, LOC110120580, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120837, LOC110120838, LOC110120839, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC112449713, LOC112449714, LOC112449715, LOC112449716, LOC112449717, LOC113939952, LOC113939953, LOC113939954, LOC121587545, LOC121847987, LOC121847988, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC125177313, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, LONP2, MIR3181, MIR6771, N4BP1, NKD1, NOD2, PHKB, RBL2, RPGRIP1L, SALL1, SIAH1, SNX20, TENT4B, TOX3, ZNF423 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr16:48576994-53913828
- GRCh38:
- Chr16:48543083-53879916
| LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, MIR3181, MIR6771, N4BP1, NKD1, NOD2, RBL2, RPGRIP1L, SALL1, SNX20, TENT4B, TOX3, ZNF423, ADCY7, AKTIP, BRD7, C16orf78, CASC16, CASC22, CBLN1, CHD9, CHD9NB, CNEP1R1, CYLD, CYLD-AS1, FTO, HEATR3, HNRNPA1L3, LINC00919, LINC01571, LINC02127, LINC02128, LINC02168, LINC02178, LINC02179, LINC02180, LINC02911, LINC03064, LOC101927272, LOC102723373, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120836, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC112449715, LOC113939952, LOC113939953, LOC113939954, LOC121587545, LOC121847987, LOC121847988 | | Ductal breast carcinoma | Uncertain significance (Jul 20, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr16:49604464-53500977
- GRCh38:
- Chr16:49570553-53467065
| ADCY7, BRD7, CASC16, CASC22, CHD9, CHD9NB, CNEP1R1, CYLD, CYLD-AS1, HEATR3, HNRNPA1L3, LINC00919, LINC01571, LINC02127, LINC02128, LINC02168, LINC02178, LINC02180, LINC02911, LINC03064, LOC101927272, LOC102723373, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120836, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC112449715, LOC113939954, LOC121587545, LOC121847987, LOC121847988, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, MIR3181, MIR6771, NKD1, NOD2, RBL2, SALL1, SNX20, TENT4B, TOX3, ZNF423 | | See cases | Pathogenic (Aug 29, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr16:49719432-68435615
- GRCh38:
- Chr16:49685521-68401712
| ACD, ADCY7, ADGRG1, ADGRG3, ADGRG5, AGRP, AKTIP, AMFR, ARL2BP, ATP6V0D1, ATP6V0D1-DT, B3GNT9, BBS2, BEAN1, BEAN1-AS1, BRD7, C16orf86, CA7, CAPNS2, CARMIL2, CASC16, CASC22, CBFB, CCDC102A, CCDC113, CCL17, CCL22, CDH11, CDH16, CDH5, CDH8, CENPT, CES1, CES2, CES3, CES4A, CES5A, CETP, CFAP20, CHD9, CHD9NB, CIAO2B, CIAPIN1, CKLF, CKLF-CMTM1, CMTM1, CMTM2, CMTM3, CMTM4, CNEP1R1, CNGB1, CNOT1, COQ9, CPNE2, CRNDE, CSNK2A2, CTCF, CTCF-DT, CTRL, CX3CL1, CYLD, CYLD-AS1, DDX28, DOK4, DPEP2, DPEP2NB, DPEP3, DRC7, DUS2, DYNC1LI2, DYNC1LI2-DT, E2F4, EDC4, ELMO3, ENKD1, ESRP2, EXOC3L1, FBXL8, FHOD1, FRA16B, FTO, FTO-IT1, GFOD2, GINS3, GNAO1, GNAO1-AS1, GNAO1-DT, GOT2, HEATR3, HERPUD1, HNRNPA1L3, HSD11B2, HSF4, IRX3, IRX5, IRX6, KATNB1, KCTD19, KIFC3, LCAT, LINC00919, LINC00920, LINC00922, LINC01571, LINC02126, LINC02127, LINC02128, LINC02137, LINC02140, LINC02141, LINC02168, LINC02169, LINC02178, LINC02180, LINC02911, LINC03064, LOC100505942, LOC101927272, LOC101927480, LOC102723373, LOC110120574, LOC110120575, LOC110120576, LOC110120577, LOC110120578, LOC110120579, LOC110120580, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120835, LOC110120836, LOC110120837, LOC110120838, LOC110120839, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC110121356, LOC110121443, LOC112449715, LOC112449716, LOC112449717, LOC112469003, LOC112469004, LOC112469005, LOC112469006, LOC112469007, LOC112469008, LOC112469009, LOC112469010, LOC112469011, LOC112469012, LOC112469013, LOC112469014, LOC112469015, LOC112469016, LOC113939954, LOC121587545, LOC121587546, LOC121587547, LOC121587548, LOC121587549, LOC121587550, LOC121587551, LOC121847987, LOC121847988, LOC121847989, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC125177313, LOC125177314, LOC125177315, LOC125177316, LOC125177317, LOC125177318, LOC125177319, LOC125177320, LOC125177322, LOC125177323, LOC125177324, LOC125177325, LOC125177326, LOC125177327, LOC125177328, LOC125177330, LOC125177332, LOC125177333, LOC125177334, LOC125177336, LOC125177337, LOC125177338, LOC125177339, LOC125177340, LOC125177341, LOC125177342, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, LOC126862355, LOC126862356, LOC126862357, LOC126862358, LOC126862359, LOC126862360, LOC126862361, LOC126862362, LOC126862363, LOC126862364, LOC126862365, LOC126862366, LOC126862367, LOC126862368, LOC126862369, LOC126862370, LOC126862371, LOC126862372, LOC126862373, LOC126862374, LOC126862375, LOC126862376, LOC126862377, LOC126862378, LOC126862379, LOC126862380, LOC126862381, LOC388282, LPCAT2, LRRC29, LRRC36, MATCAP1, MIR138-2, MIR3181, MIR328, MIR3935, MIR6771, MIR6772, MIR6773, MIR6863, MMP15, MMP2, MMP2-AS1, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, MT2A, MT3, MT4, NAE1, NDRG4, NFATC3, NKD1, NLRC5, NOD2, NOL3, NRN1L, NUDT21, NUP93, NUP93-DT, NUTF2, OGFOD1, PARD6A, PDP2, PHAF1, PLA2G15, PLEKHG4, PLLP, POLR2C, PRMT7, PRSS54, PSKH1, PSMB10, PSME3IP1, RANBP10, RBL2, RIPOR1, RPGRIP1L, RRAD, RSPRY1, SALL1, SETD6, SLC12A3, SLC12A4, SLC38A7, SLC6A2, SLC7A6, SLC7A6OS, SLC9A5, SMPD3, SNORA46, SNORA50A, SNX20, TENT4B, TEPP, TERB1, THAP11, TK2, TMEM208, TOX3, TPPP3, TRADD, TRL-CAG2-1, TRL-CAG2-2, TSNAXIP1, USB1, ZDHHC1, ZNF319, ZNF423 | | See cases | Pathogenic (Mar 18, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr16:49774718-51910531
- GRCh38:
- Chr16:49740807-51876620
| ADCY7, BRD7, CNEP1R1, CYLD, CYLD-AS1, HEATR3, HNRNPA1L3, LINC01571, LINC02127, LINC02128, LINC02168, LINC02178, LOC101927272, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120836, LOC110120841, LOC110120939, LOC112449715, LOC113939954, LOC121587545, LOC121847987, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, MIR3181, MIR6771, NKD1, NOD2, SALL1, SNX20, TENT4B, ZNF423 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr16:50818240-55600627
- GRCh38:
- Chr16:50784329-55566715
| AKTIP, CAPNS2, CASC16, CASC22, CHD9, CHD9NB, CRNDE, CYLD, FTO, FTO-IT1, HNRNPA1L3, IRX3, IRX5, IRX6, LINC00919, LINC01571, LINC02127, LINC02128, LINC02140, LINC02168, LINC02169, LINC02180, LINC02911, LINC03064, LOC101927480, LOC102723373, LOC110120574, LOC110120575, LOC110120576, LOC110120577, LOC110120578, LOC110120579, LOC110120580, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120835, LOC110120836, LOC110120837, LOC110120838, LOC110120839, LOC110120840, LOC110120841, LOC110120939, LOC110121339, LOC112449716, LOC112449717, LOC112469003, LOC121847988, LOC125177311, LOC125177312, LOC125177313, LOC125177314, LOC125177315, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, LOC126862355, LOC126862356, LOC126862357, LPCAT2, MMP2, MMP2-AS1, RBL2, RPGRIP1L, SALL1, TOX3 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51169910-51169911
- GRCh38:
- Chr16:51135999-51136000
| SALL1 | | Townes-Brocks syndrome 1 | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51169989-51169990
- GRCh38:
- Chr16:51136078-51136079
| SALL1 | | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170095-51170097
- GRCh38:
- Chr16:51136184-51136186
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51170317-51170318
- GRCh38:
- Chr16:51136406-51136407
| SALL1 | | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170435
- GRCh38:
- Chr16:51136524
| SALL1 | | Townes-Brocks syndrome 1 | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170460
- GRCh38:
- Chr16:51136549
| SALL1 | | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170930-51170931
- GRCh38:
- Chr16:51137019-51137020
| SALL1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170931-51170935
- GRCh38:
- Chr16:51137020-51137024
| SALL1 | | Townes-Brocks syndrome 1, not provided | Likely benign (Mar 31, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171034
- GRCh38:
- Chr16:51137123
| SALL1 | V1225I, V1322I | not provided, Townes syndrome, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Nov 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51171035
- GRCh38:
- Chr16:51137124
| SALL1 | I1224M, I1321M | not provided | Benign (Oct 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171041
- GRCh38:
- Chr16:51137130
| SALL1 | | not provided, Townes syndrome | Likely benign (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171051
- GRCh38:
- Chr16:51137140
| SALL1 | E1316G, E1219G | Inborn genetic diseases | Uncertain significance (Oct 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171056
- GRCh38:
- Chr16:51137145
| SALL1 | | not provided, not specified, Townes-Brocks syndrome 1, Townes syndrome | Benign/Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171060
- GRCh38:
- Chr16:51137149
| SALL1 | R1313H, R1216H | Inborn genetic diseases, Townes syndrome, not provided
| Conflicting interpretations of pathogenicity (Jul 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51171061
- GRCh38:
- Chr16:51137150
| SALL1 | R1313C, R1216C | Townes syndrome | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171083
- GRCh38:
- Chr16:51137172
| SALL1 | | Townes syndrome, not specified, not provided
| Benign (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171108
- GRCh38:
- Chr16:51137197
| SALL1 | L1297R, L1200R | Townes syndrome, Inborn genetic diseases | Uncertain significance (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171126
- GRCh38:
- Chr16:51137215
| SALL1 | N1291S, N1194S | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171151
- GRCh38:
- Chr16:51137240
| SALL1 | E1186K, E1283K | Townes-Brocks syndrome 1 | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171155
- GRCh38:
- Chr16:51137244
| SALL1 | N1184K, N1281K | Townes syndrome | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171162
- GRCh38:
- Chr16:51137251
| SALL1 | T1182M, T1279M | Inborn genetic diseases, Townes syndrome, not provided
| Uncertain significance (Mar 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171175
- GRCh38:
- Chr16:51137264
| SALL1 | V1275I, V1178I | not provided, not specified, Townes syndrome, Townes-Brocks syndrome 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171190
- GRCh38:
- Chr16:51137279
| SALL1 | G1173R, G1270R | not specified | Uncertain significance (Feb 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171197
- GRCh38:
- Chr16:51137286
| SALL1 | | Townes syndrome | Likely benign (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171204
- GRCh38:
- Chr16:51137293
| SALL1 | G1265E, G1168E | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Sep 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171211
- GRCh38:
- Chr16:51137300
| SALL1 | I1166V, I1263V | Townes-Brocks syndrome 1 | Uncertain significance (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171216
- GRCh38:
- Chr16:51137305
| SALL1 | P1164R, P1261R | Townes-Brocks syndrome 1, not provided | Uncertain significance (Dec 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171216
- GRCh38:
- Chr16:51137305
| SALL1 | P1164L, P1261L | Townes-Brocks syndrome 1 | Uncertain significance (Aug 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171217
- GRCh38:
- Chr16:51137306
| SALL1 | P1164S, P1261S | Inborn genetic diseases | Uncertain significance (Oct 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171227
- GRCh38:
- Chr16:51137316
| SALL1 | | not specified, Townes syndrome, Townes-Brocks syndrome 1
| Likely benign (Feb 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171239
- GRCh38:
- Chr16:51137328
| SALL1 | | Townes syndrome, not provided | Likely benign (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171248
- GRCh38:
- Chr16:51137337
| SALL1 | | not provided, Townes syndrome | Conflicting interpretations of pathogenicity (Aug 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51171261
- GRCh38:
- Chr16:51137350
| SALL1 | A1149V, A1246V | Inborn genetic diseases | Uncertain significance (Jul 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171269
- GRCh38:
- Chr16:51137358
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171270
- GRCh38:
- Chr16:51137359
| SALL1 | N1146S, N1243S | Townes-Brocks syndrome 1, Townes syndrome | Uncertain significance (May 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171278
- GRCh38:
- Chr16:51137367
| SALL1 | | Townes syndrome | Likely benign (Aug 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171302
- GRCh38:
- Chr16:51137391
| SALL1 | S1232R, S1135R | Inborn genetic diseases | Uncertain significance (Jul 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171313
- GRCh38:
- Chr16:51137402
| SALL1 | D1132N, D1229N | not provided, Inborn genetic diseases | Uncertain significance (Feb 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171332
- GRCh38:
- Chr16:51137421
| SALL1 | | Townes syndrome | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171333
- GRCh38:
- Chr16:51137422
| SALL1 | A1125V, A1222V | Townes syndrome, not provided | Benign/Likely benign (Sep 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171367
- GRCh38:
- Chr16:51137456
| SALL1 | V1114F, V1211F | Townes-Brocks syndrome 1, not provided | Uncertain significance (Nov 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171368
- GRCh38:
- Chr16:51137457
| SALL1 | | Townes syndrome | Likely benign (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171375
- GRCh38:
- Chr16:51137464
| SALL1 | G1111D, G1208D | not provided | Uncertain significance (Jul 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171395
- GRCh38:
- Chr16:51137484
| SALL1 | | not provided | Benign (Jun 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171397
- GRCh38:
- Chr16:51137486
| SALL1 | G1201S, G1104S | not provided | Uncertain significance (Aug 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171414
- GRCh38:
- Chr16:51137503
| SALL1 | R1195Q, R1098Q | Townes syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171461
- GRCh38:
- Chr16:51137550
| SALL1 | | Townes syndrome | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171494-51171495
- GRCh38:
- Chr16:51137583-51137584
| SALL1 | | not provided, not specified | Benign/Likely benign (Aug 11, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171615
- GRCh38:
- Chr16:51137704
| SALL1 | | not provided | Likely benign (Nov 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171670
- GRCh38:
- Chr16:51137759
| SALL1 | | not provided | Benign (Jun 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172325
- GRCh38:
- Chr16:51138414
| SALL1 | | not provided | Benign (Jun 28, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172559
- GRCh38:
- Chr16:51138648
| SALL1 | | not provided | Benign (Dec 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172594
- GRCh38:
- Chr16:51138683
| SALL1 | | not specified | Likely benign (Jan 4, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172677
- GRCh38:
- Chr16:51138766
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1, not specified | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172696
- GRCh38:
- Chr16:51138785
| SALL1 | S1049L, S1146L | Townes syndrome | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172718-51172719
- GRCh38:
- Chr16:51138807-51138808
| SALL1 | C1042fs, C1139fs | not provided, Townes-Brocks syndrome 1, Townes syndrome
| Pathogenic (Jul 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172724
- GRCh38:
- Chr16:51138813
| SALL1 | N1040D, N1137D | Townes syndrome | Uncertain significance (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172752
- GRCh38:
- Chr16:51138841
| SALL1 | R1031fs, R1128fs | Townes-Brocks syndrome 1 | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172753
- GRCh38:
- Chr16:51138842
| SALL1 | P1030L, P1127L | not provided | Benign (May 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172786
- GRCh38:
- Chr16:51138875
| SALL1 | S1019F, S1116F | Townes syndrome | Uncertain significance (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172803
- GRCh38:
- Chr16:51138892
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Likely benign (Dec 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172806
- GRCh38:
- Chr16:51138895
| SALL1 | | Townes syndrome | Likely benign (Dec 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172807
- GRCh38:
- Chr16:51138896
| SALL1 | P1109L, P1012L | not provided | Likely pathogenic (Mar 31, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172811
- GRCh38:
- Chr16:51138900
| SALL1 | V1011F, V1108F | Townes-Brocks syndrome 1 | Uncertain significance (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172811
- GRCh38:
- Chr16:51138900
| SALL1 | V1011L, V1108L | not provided, Townes syndrome | Benign/Likely benign (Jan 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172811
- GRCh38:
- Chr16:51138900
| SALL1 | V1011I, V1108I | not specified, Townes-Brocks syndrome 1 | Likely benign (Dec 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172823
- GRCh38:
- Chr16:51138912
| SALL1 | P1007A, P1104A | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172828
- GRCh38:
- Chr16:51138917
| SALL1 | D1102G, D1005G | not provided | Uncertain significance (May 17, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172863
- GRCh38:
- Chr16:51138952
| SALL1 | | Townes syndrome, not provided | Conflicting interpretations of pathogenicity (Jul 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51172891
- GRCh38:
- Chr16:51138980
| SALL1 | L1081S, L984S | not provided | Likely benign (Dec 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172902
- GRCh38:
- Chr16:51138991
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1 | Likely benign (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172911
- GRCh38:
- Chr16:51139000
| SALL1 | | not provided | Uncertain significance (Aug 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172911
- GRCh38:
- Chr16:51139000
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172934
- GRCh38:
- Chr16:51139023
| SALL1 | L1067F, L970F | Townes-Brocks syndrome 1, Townes syndrome | Conflicting interpretations of pathogenicity (Jul 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51172953
- GRCh38:
- Chr16:51139042
| SALL1 | | Townes syndrome | Likely benign (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172953
- GRCh38:
- Chr16:51139042
| SALL1 | | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172960
- GRCh38:
- Chr16:51139049
| SALL1 | S1058C, S961C | not provided | Uncertain significance (Jul 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172973
- GRCh38:
- Chr16:51139062
| SALL1 | R1054*, R957* | Townes syndrome, not provided | Pathogenic/Likely pathogenic (Nov 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172976
- GRCh38:
- Chr16:51139065
| SALL1 | M1053L, M956L | not provided | Uncertain significance (Aug 5, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172979
- GRCh38:
- Chr16:51139068
| SALL1 | Q1052*, Q955* | not provided | Likely pathogenic (Aug 5, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173013
- GRCh38:
- Chr16:51139102
| SALL1 | | not specified, not provided, Townes syndrome, Townes-Brocks syndrome 1 | Benign/Likely benign (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173027-51173028
- GRCh38:
- Chr16:51139116-51139117
| SALL1 | R1036fs, R939fs | not provided | Pathogenic (Sep 22, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173038
- GRCh38:
- Chr16:51139127
| SALL1 | T1032I, T935I | Townes syndrome | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173045
- GRCh38:
- Chr16:51139134
| SALL1 | I1030V, I933V | Townes syndrome, Townes-Brocks syndrome 1 | Uncertain significance (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173049
- GRCh38:
- Chr16:51139138
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Likely benign (Aug 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173065
- GRCh38:
- Chr16:51139154
| SALL1 | H1023P, H926P | not provided | Uncertain significance (Apr 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173112
- GRCh38:
- Chr16:51139201
| SALL1 | | not provided | Uncertain significance (Dec 5, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173125-51173128
- GRCh38:
- Chr16:51139214-51139217
| SALL1 | A1002fs, A905fs | Townes syndrome | Pathogenic (Oct 23, 2018) | criteria provided, single submitter |